Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  1997-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.41.9.1933PMID 9303387PMCID PMC164038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli

  1997cited by this paper
• In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis

  1995cited by this paper
• Antibiotic concerns in the elderly. A clinician's perspective.

  1995cited by this paper
• Treatment of infections in elderly patients.

  1995cited by this paper
• Antibiotic concerns in the elderly. A clinician's perspective.

  1995cited by this paper
• Antibiotics at the extremes of age: choices and constraints.

  1994cited by this paper
• Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes

  1994cited by this paper
• Biopharmaceutical aspects of anti-infective therapy at the extremes of age.

  1994cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities

  1993cited by this paper
• Quinolone antimicrobial agents.

  1992cited by this paper
• Altered cellular responsiveness during ageing.

  1991cited by this paper
• Studies in the distribution of body fat: I. Effects of age, sex, and obesity.

  1989cited by this paper
• Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis

  1988cited by this paper
• Age‐dependent Differences in Outcome of Infections, with Special Reference to Experiments in Mice

  1982cited by this paper
• Investigation of host defense mechanisms in the aged as determinants of nosocomial colonization and pneumonia.

  1978cited by this paper
• Appendicitis in the Elderly

  1978cited by this paper
• Age-related decline in the resistance of mice to infection with intracellular pathogens

  1977cited by this paper
• The decline of cell-mediated immunity in aging mice.

  1974cited by this paper
• Experimental Intra-Abdominal Abscesses in Rats: Development of an Experimental Model

  1974cited by this paper
• Abdominal trauma, anaerobes, and antibiotics.

  1973cited by this paper

• Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities

  2017cites this paper
• Animal Models to Evaluate Anti-infective Pharmacodynamics

  2016cites this paper
• Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.

  2016cites this paper
• Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model

  2005cites this paper
• Immunomodulatory Activities of Fluoroquinolones

  2005cites this paper
• Anti-inflammatory properties of antibiotics other than macrolides

  2005cites this paper
• Antibiotics as Anti-inflammatory and Immunomodulatory Agents

  2005cites this paper
• Efficacy of telithromycin in the treatment of experimental Bacteroides fragilis intraabdominal abscess in the senescent mice.

  2004cites this paper
• Anti-Inflammatory Effects of Moxifloxacin on Activated Human Monocytic Cells: Inhibition of NF-κB and Mitogen-Activated Protein Kinase Activation and of Synthesis of Proinflammatory Cytokines

  2004cites this paper
• of Proinflammatory Cytokines Protein Kinase Activation and of Synthesis B and Mitogen-Activated κ Inhibition of NF-on Activated Human Monocytic Cells : Anti-Inflammatory Effects of Moxifloxacin

  2004cites this paper
• Therapeutic Efficacy of Moxifloxacin, a New Quinolone, in the Treatment of Experimental Intra-Abdominal Abscesses Induced by Bacteroides fragilis in Mice

  2004cites this paper
• Effects of Age on Mortality and Antibiotic Efficacy in Cecal Ligation and Puncture

  2003cites this paper
• Emergence of fluoroquinolone resistance among Bacteroides species.

  2003cites this paper
• Immunomodulatory effects of quinolones.

  2003cites this paper
• In Vivo Efficacy of Trovafloxacin against Bacteroides fragilis in Mixed Infection with either Escherichia coli or a Vancomycin-Resistant Strain of Enterococcus faecium in an Established-Abscess Murine Model

  2001cites this paper
• Salmonella typhimurium-induced reactivation of latent HIV-1 in promonocytic U1 cells is inhibited by trovafloxacin.

  2000cites this paper
• The Role of Quinolones in Abdominal Surgery

  2000cites this paper
• Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.

  2000cites this paper
• Failure of Alatrofloxacin in Patients with Deep Surgical Infection

  1999cites this paper
• Trovafloxacin: A New Fluoroquinolone

  1999cites this paper
• Chapter 31. To Market, To Market - 1998

  1999cites this paper
• Chapter 14 - Recent Developments in Antibacterial Research

  1998cites this paper